gyy-4137 and Esophageal-Squamous-Cell-Carcinoma

gyy-4137 has been researched along with Esophageal-Squamous-Cell-Carcinoma* in 1 studies

Other Studies

1 other study(ies) available for gyy-4137 and Esophageal-Squamous-Cell-Carcinoma

Article	Year
HA-ADT suppresses esophageal squamous cell carcinoma progression via apoptosis promotion and autophagy inhibition. Experimental cell research, 2022, 11-01, Volume: 420, Issue:1 Topics: Apoptosis; Autophagy; beta Catenin; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Glycogen Synthase Kinase 3 beta; Humans; Hyaluronic Acid; Hydrogen Sulfide; Morpholines; Organothiophosphorus Compounds; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Sulfides; Thiones; TOR Serine-Threonine Kinases	2022

Article

Year

HA-ADT suppresses esophageal squamous cell carcinoma progression via apoptosis promotion and autophagy inhibition.

Experimental cell research, 2022, 11-01, Volume: 420, Issue:1

Topics: Apoptosis; Autophagy; beta Catenin; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Glycogen Synthase Kinase 3 beta; Humans; Hyaluronic Acid; Hydrogen Sulfide; Morpholines; Organothiophosphorus Compounds; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Sulfides; Thiones; TOR Serine-Threonine Kinases

2022